RhumbLine Advisers’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,198,565
| Closed | -$119M | – | 2986 |
|
|
2019
Q3 | $119M | Buy |
1,198,565
+23,035
| +2% | +$2.19M | 0.22% | 86 |
|
|
2019
Q2 | $109M | Buy |
1,175,530
+434
| +0% | +$41.2K | 0.2% | 93 |
|
|
2019
Q1 | $111M | Buy |
1,175,096
+54,050
| +5% | +$4.73M | 0.21% | 89 |
|
|
2018
Q4 | $71.8M | Sell |
1,121,046
-6,606
| -0.6% | -$488K | 0.16% | 125 |
|
|
2018
Q3 | $101M | Sell |
1,127,652
-34,440
| -3% | -$3.04M | 0.19% | 100 |
|
|
2018
Q2 | $92.3M | Sell |
1,162,092
-20,624
| -2% | -$1.71M | 0.19% | 106 |
|
|
2018
Q1 | $106M | Sell |
1,182,716
-51,919
| -4% | -$4.98M | 0.22% | 88 |
|
|
2017
Q4 | $129M | Sell |
1,234,635
-90,069
| -7% | -$10.2M | 0.26% | 72 |
|
|
2017
Q3 | $193M | Buy |
1,324,704
+12,344
| +0.9% | +$1.68M | 0.42% | 41 |
|
|
2017
Q2 | $170M | Buy |
1,312,360
+32,357
| +3% | +$3.96M | 0.39% | 42 |
|
|
2017
Q1 | $159M | Buy |
1,280,003
+10,679
| +0.8% | +$1.28M | 0.37% | 43 |
|
|
2016
Q4 | $147M | Buy |
1,269,324
+36,632
| +3% | +$4.08M | 0.37% | 47 |
|
|
2016
Q3 | $129M | Buy |
1,232,692
+42,159
| +4% | +$4.56M | 0.36% | 48 |
|
|
2016
Q2 | $117M | Buy |
1,190,533
+41,312
| +4% | +$4.27M | 0.35% | 50 |
|
|
2016
Q1 | $115M | Buy |
1,149,221
+36,689
| +3% | +$3.78M | 0.36% | 52 |
|
|
2015
Q4 | $133M | Sell |
1,112,532
-6,767
| -0.6% | -$783K | 0.43% | 44 |
|
|
2015
Q3 | $121M | Buy |
1,119,299
+14,304
| +1% | +$1.78M | 0.41% | 47 |
|
|
2015
Q2 | $128M | Sell |
1,104,995
-199,638
| -15% | -$22.8M | 0.41% | 46 |
|
|
2015
Q1 | $150M | Sell |
1,304,633
-12,315
| -0.9% | -$1.47M | 0.43% | 47 |
|
|
2014
Q4 | $147M | Sell |
1,316,948
-24,334
| -2% | -$2.57M | 0.43% | 43 |
|
|
2014
Q3 | $127M | Sell |
1,341,282
-26,114
| -2% | -$2.36M | 0.38% | 49 |
|
|
2014
Q2 | $117M | Sell |
1,367,396
-84,698
| -6% | -$6.44M | 0.34% | 56 |
|
|
2014
Q1 | $101M | Sell |
1,452,094
-24,800
| -2% | -$1.96M | 0.3% | 69 |
|
|
2013
Q4 | $125M | Sell |
1,476,894
-71,238
| -5% | -$5.64M | 0.37% | 53 |
|
|
2013
Q3 | $119M | Sell |
1,548,132
-52,570
| -3% | -$3.68M | 0.37% | 53 |
|
|
2013
Q2 | $93.6M | Buy |
+1,600,702
| New | +$96.3M | 0.3% | 65 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
RhumbLine Advisers's CELG Position: Q4 2019 in Review
RhumbLine Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,198,565 shares — an estimated $119M sold.
RhumbLine Advisers first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $193M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- RhumbLine Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- RhumbLine Advisers sold 1,198,565 Celgene Corp shares in Q4 2019, an estimated $119M.
- RhumbLine Advisers first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- RhumbLine Advisers's Celgene Corp position peaked at $193M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.